DexCom, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 17.47%

DexCom, Inc. EBIT Margin is 17.47% for the Trailing 12 Months (TTM) ending March 31, 2025, a -16.85% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • DexCom, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 21.01%, a 45.04% change year over year.
  • DexCom, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 14.48%, a 37.28% change year over year.
  • DexCom, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 10.55%, a -32.74% change year over year.
  • DexCom, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 15.69%, a 17.33% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin